TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT04775537: OssiMend BA in Posterolateral Instrumented Lumbar Fusion

Sponsor: Collagen Matrix · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 120 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$8,300,000

Rescue Site Savings

+$5,478,000

Unlock Full NCT04775537 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04775537 Rescue Dossier →